Desmopressin: A new Principle for Symptomatic Treatment of Urgency and Incontinence in Patients with Multiple Sclerosis
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 24 (2) , 109-112
- https://doi.org/10.3109/00365599009180373
Abstract
Thirteen patients with advanced multiple sclerosis and urge urinary incontinence were treated with desmopressin–a synthetic analogue of antidiuretic hormone in a double-blind cross-over study. The micturition frequency decreased significantly (p<0.05). Less leakage was considered valuable for daily life. Peroral medication was favourable in these patients with muscular dysfunction. Side-effects were few.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of intranasal and oral desmopressin for nocturnal enuresis.Archives of Disease in Childhood, 1987
- Oral desmopressin in central diabetes insipidus.Archives of Disease in Childhood, 1986
- Drugs Five Years Later: DesmopressinAnnals of Internal Medicine, 1985
- Vesical dysfunction in multiple sclerosisUrology, 1985
- Desmopressin Response of Enuretic ChildrenAmerican Journal of Diseases of Children, 1983
- The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- The Use of Desmopressin (DDAVP) in Nocturna Urinary Frequency in the FemaleBritish Journal of Urology, 1982
- Evaluation of a Synthetic Vasopressin Analogue for Treatment of Nocturia in Benign Prostatic HypertrophyScandinavian Journal of Urology and Nephrology, 1980
- 1-Deamino-8-d-arginine vasopressin in the treatment of central diabetes insipidus in childhoodThe Journal of Pediatrics, 1978
- DESMOPRESSIN AS A TREATMENT FOR ENURESISThe Lancet, 1977